{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:22:52Z","timestamp":1792592572975,"version":"4.5.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1053\/j.gastro.2025.12.041","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T16:19:45Z","timestamp":1773332385000},"page":"1457-1472","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Evaluation of Abnormal Liver Biochemical Test Results"],"prefix":"10.1053","volume":"170","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8234-4485","authenticated-orcid":false,"given":"Paul Y.","family":"Kwo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard C.","family":"Masuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esperance A.","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence S.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2025.12.041_bib1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.12.041_bib3","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.12.041_bib4","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/hep.24752","article-title":"Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: results from the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial","volume":"55","author":"Everson","year":"2012","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.12.041_bib5","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1572-0241.2003.07486.x","article-title":"The prevalence and etiology of elevated aminotransferase levels in the United States","volume":"98","author":"Clark","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2025.12.041_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101553","article-title":"Prevalence of abnormal liver tests and liver fibrosis among rural adults in low and middle-income country: a cross-sectional study","volume":"51","author":"Ramakrishnan","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1053\/j.gastro.2025.12.041_bib7","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/hep.22109","article-title":"Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease","volume":"47","author":"Kim","year":"2008","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.12.041_bib8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0009-9120(90)80062-N","article-title":"Aspartate aminotransferase isoenzymes","volume":"23","author":"Panteghini","year":"1990","journal-title":"Clin Biochem"},{"key":"10.1053\/j.gastro.2025.12.041_bib9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ajg.2016.517","article-title":"ACG clinical guideline: evaluation of abnormal liver chemistries","volume":"112","author":"Kwo","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2025.12.041_bib10","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/apt.17914","article-title":"Upper limit of normal ALT levels in health and metabolic diseases: pooled analysis of 423,355 individuals with bootstrap modelling","volume":"59","author":"Tan","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2025.12.041_bib11","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.12.041_bib12","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.3748\/wjg.v30.i27.3264","article-title":"Effects of excess high-normal alanine aminotransferase levels in relation to new-onset metabolic dysfunction-associated fatty liver disease: clinical implications","volume":"30","author":"McGinty","year":"2024","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2025.12.041_bib13","first-page":"99","article-title":"Measurement of aminotransferases: part 1. Aspartate aminotransferase","volume":"21","author":"Rej","year":"1984","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1053\/j.gastro.2025.12.041_bib14","doi-asserted-by":"crossref","first-page":"748","DOI":"10.5858\/arpa.2018-0622-OA","article-title":"Alanine aminotransferase results differ by analyzer manufacturer in a national integrated health setting, 2012-2017","volume":"144","author":"Beste","year":"2020","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.gastro.2025.12.041_bib15","doi-asserted-by":"crossref","first-page":"ofad484","DOI":"10.1093\/ofid\/ofad484","article-title":"Herpes simplex virus hepatitis in patients requiring intensive care unit admission: a retrospective, multicenter, observational study","volume":"10","author":"Frapard","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1053\/j.gastro.2025.12.041_bib16","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.cgh.2018.08.016","article-title":"A multicenter study into causes of severe acute liver injury","volume":"17","author":"Breu","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.12.041_bib17","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/alcalc\/agh074","article-title":"High AST\/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking","volume":"39","author":"Nyblom","year":"2004","journal-title":"Alcohol Alcohol"},{"key":"10.1053\/j.gastro.2025.12.041_bib18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41392-020-0128-8","article-title":"Mitochondrial dysfunction and alcohol-associated liver disease: a novel pathway and therapeutic target","volume":"5","author":"Abdallah","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1053\/j.gastro.2025.12.041_bib19","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1053\/j.gastro.2016.02.042","article-title":"Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA Alcoholic Hepatitis Consortia","volume":"150","author":"Crabb","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.12.041_bib20","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1056\/NEJMra1903585","article-title":"Current and emerging issues in Wilson\u2019s disease","volume":"389","author":"Roberts","year":"2023","journal-title":"New Engl J Med"},{"key":"10.1053\/j.gastro.2025.12.041_bib21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1572-0241.1998.044_c.x","article-title":"AST\/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection","volume":"93","author":"Sheth","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2025.12.041_bib22","first-page":"458","article-title":"Immunoglobulin complexed AST (\u201cmacro-AST\u201d) in an asymptomatic child with persistent hypertransaminasemia","volume":"15","author":"Vajro","year":"1992","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1053\/j.gastro.2025.12.041_bib23","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1002\/hep.27715","article-title":"Liver alkaline phosphatase: a missing link between choleresis and biliary inflammation","volume":"61","author":"Poupon","year":"2015","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.12.041_bib24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/cld.872","article-title":"Inherited cholestatic diseases in the era of personalized medicine","volume":"15","author":"Goldberg","year":"2020","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"10.1053\/j.gastro.2025.12.041_bib25","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1056\/NEJMra1816149","article-title":"Drug-induced liver injury \u2014 types and phenotypes","volume":"381","author":"Hoofnagle","year":"2019","journal-title":"New Engl J Med"},{"key":"10.1053\/j.gastro.2025.12.041_bib26","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.12.041_bib27","doi-asserted-by":"crossref","first-page":"405","DOI":"10.14309\/ajg.0000000000002190","article-title":"ACG clinical guideline: diagnosis and management of biliary strictures","volume":"118","author":"Elmunzer","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2025.12.041_bib28","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s40264-018-0654-2","article-title":"Drug-induced liver injury: why is the Roussel Uclaf Causality Assessment Method (RUCAM) still used 25 years after its launch?","volume":"41","author":"Danan","year":"2018","journal-title":"Drug Saf"},{"key":"10.1053\/j.gastro.2025.12.041_bib29","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/pds.5099","article-title":"Comparison of laboratory threshold criteria in drug-induced liver injury detection algorithms for use in pharmacovigilance","volume":"29","author":"Tan","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1053\/j.gastro.2025.12.041_bib30","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1093\/clinchem\/46.12.2050","article-title":"Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring","volume":"46","author":"Dufour","year":"2000","journal-title":"Clin Chem"},{"key":"10.1053\/j.gastro.2025.12.041_bib31","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1053\/j.gastro.2021.08.015","article-title":"AGA clinical practice guideline on the management of coagulation disorders in patients with cirrhosis","volume":"161","author":"O\u2019Shea","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.12.041_bib32","series-title":"Diseases of the Liver and Bile Ducts: A Practical Guide to Diagnosis and Treatment","first-page":"43","article-title":"True liver function tests","author":"Chaiwala","year":"1998"},{"key":"10.1053\/j.gastro.2025.12.041_bib34","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/apt.18054","article-title":"Liver function and portal-systemic shunting quantified by the oral cholate challenge test and risk for large oesophageal varices","volume":"60","author":"Hassanein","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2025.12.041_bib35","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.cgh.2024.07.009","article-title":"Biomarkers for prediction of alcohol-related liver cirrhosis: a general population-based Swedish study of 537,250 individuals","volume":"23","author":"Jakobsson","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.12.041_bib36","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.14309\/ajg.0000000000000315","article-title":"ACG clinical guideline: hereditary hemochromatosis","volume":"114","author":"Kowdley","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2025.12.041_bib37","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1007\/s00109-022-02254-8","article-title":"Iron and iron-related proteins in alcohol consumers: cellular and clinical aspects","volume":"100","author":"Ferrao","year":"2022","journal-title":"J Mol Med (Berl)"},{"key":"10.1053\/j.gastro.2025.12.041_bib38","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jhep.2011.05.008","article-title":"Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target","volume":"55","author":"Dongiovanni","year":"2011","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.12.041_bib39","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1053\/j.gastro.2017.03.017","article-title":"American Gastroenterological Association Institute Guideline on the role of elastography in the evaluation of liver fibrosis","volume":"152","author":"Lim","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.12.041_bib40","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jhep.2016.09.017","article-title":"Extensive testing or focused testing of patients with elevated liver enzymes","volume":"66","author":"Tapper","year":"2017","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.12.041_bib41","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMra1610570","article-title":"Use of liver imaging and biopsy in clinical practice","volume":"377","author":"Tapper","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2025.12.041_bib42","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/pbc.21423","article-title":"Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis","volume":"50","author":"Allen","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1053\/j.gastro.2025.12.041_bib43","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/HEP.0000000000000845","article-title":"AASLD practice guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis","volume":"81","author":"Sterling","year":"2025","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.12.041_bib44","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1038\/s41591-023-02539-6","article-title":"Diagnostic performance of circulating biomarkers for non-alcoholic steatohepatitis","volume":"29","author":"Sanyal","year":"2023","journal-title":"Nat Med"},{"key":"10.1053\/j.gastro.2025.12.041_bib45","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/hep.510290318","article-title":"Chronic unexplained hypertransaminasemia may be caused by occult celiac disease","volume":"29","author":"Bardella","year":"1999","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.12.041_bib46","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0140-6736(97)11222-3","article-title":"Coeliac disease hidden by cryptogenic hypertransaminasaemia","volume":"352","author":"Volta","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2025.12.041_bib47","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1542-3565(03)00313-6","article-title":"Liver abnormalities in celiac disease","volume":"2","author":"Abdo","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.12.041_bib48","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s40618-020-01208-6","article-title":"The interplay between thyroid and liver: implications for clinical practice","volume":"43","author":"Piantanida","year":"2020","journal-title":"J Endocrinol Invest"},{"key":"10.1053\/j.gastro.2025.12.041_bib49","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1089\/thy.2020.0715","article-title":"Abnormal liver blood tests in patients with hyperthyroidism: systematic review and meta-analysis","volume":"31","author":"Scappaticcio","year":"2021","journal-title":"Thyroid"},{"key":"10.1053\/j.gastro.2025.12.041_bib50","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1136\/gutjnl-2024-332491","article-title":"Association between primary hypothyroidism and metabolic dysfunction-associated steatotic liver disease: an updated meta-analysis","volume":"73","author":"Mantovani","year":"2024","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2025.12.041_bib51","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/s-0031-1284434","article-title":"Liver abnormalities in cardiac diseases and heart failure","volume":"20","author":"Alvarez","year":"2011","journal-title":"Int J Angiol"},{"key":"10.1053\/j.gastro.2025.12.041_bib52","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1186\/s12876-021-02038-3","article-title":"FIB-4, APRI, and AST\/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran","volume":"21","author":"Amernia","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"10.1053\/j.gastro.2025.12.041_bib53","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S1665-2681(19)31836-8","article-title":"AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis","volume":"7","author":"Loaeza-del-Castillo","year":"2008","journal-title":"Ann Hepatol"},{"key":"10.1053\/j.gastro.2025.12.041_bib54","article-title":"Diagnostic role of the fibrosis-4 index and nonalcoholic fatty liver disease fibrosis score as a noninvasive tool for liver fibrosis scoring","volume":"103","author":"Chen","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.gastro.2025.12.041_bib55","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.12.041_bib56","article-title":"Reappraisal of fibrosis-4 index and non-alcoholic fatty liver disease fibrosis score for advanced fibrosis in average-risk population","volume":"3","author":"Park","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1053\/j.gastro.2025.12.041_bib57","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3138\/canlivj-2024-0063","article-title":"Validation of FIB-4 for the diagnosis of liver cirrhosis in metabolic dysfunction-associated steatotic liver disease","volume":"8","author":"Bera","year":"2025","journal-title":"Can Liver J"},{"key":"10.1053\/j.gastro.2025.12.041_bib58","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Shah","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.12.041_bib59","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-230X-6-6","article-title":"Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease","volume":"6","author":"Ratziu","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"10.1053\/j.gastro.2025.12.041_bib60","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.3390\/jcm10112415","article-title":"FibroTest for evaluating fibrosis in non-alcoholic fatty liver disease patients: a systematic review and meta-analysis","volume":"10","author":"Vali","year":"2021","journal-title":"J Clin Med"},{"key":"10.1053\/j.gastro.2025.12.041_bib61","doi-asserted-by":"crossref","DOI":"10.4254\/wjh.v17.i3.104534","article-title":"Diagnostic performance of FibroTest-ActiTest, transient elastography, and the fibrosis-4 index in patients with autoimmune hepatitis using histological reference","volume":"17","author":"Peta","year":"2025","journal-title":"World J Hepatol"},{"key":"10.1053\/j.gastro.2025.12.041_bib62","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2893.2009.01263.x","article-title":"Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C","volume":"18","author":"Parkes","year":"2011","journal-title":"J Viral Hepat"},{"key":"10.1053\/j.gastro.2025.12.041_bib63","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jhep.2020.03.036","article-title":"Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: a systematic review and meta-analysis","volume":"73","author":"Vali","year":"2020","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.12.041_bib64","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jhep.2023.04.002","article-title":"Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease","volume":"79","author":"Kjaergaard","year":"2023","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.12.041_bib65","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s12876-021-01795-5","article-title":"The enhanced liver fibrosis test maintains its diagnostic and prognostic performance in alcohol-related liver disease: a cohort study","volume":"21","author":"Connoley","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"10.1053\/j.gastro.2025.12.041_bib66","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/hep.22517","article-title":"Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay","volume":"48","author":"Mayo","year":"2008","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.12.041_bib67","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.12.041_bib68","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep.24105","article-title":"Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis","volume":"53","author":"Lin","year":"2011","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.12.041_bib69","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jceh.2016.08.001","article-title":"Noninvasive assessment of liver fibrosis by transient elastography and FIB4\/APRI for prediction of treatment response in chronic hepatitis C\u2014an experience from a tertiary care hospital","volume":"6","author":"Taneja","year":"2016","journal-title":"J Clin Exp Hepatol"},{"key":"10.1053\/j.gastro.2025.12.041_bib70","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and FibroTest","volume":"46","author":"Vallet-Pichard","year":"2007","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.12.041_bib71","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/hep.27382","article-title":"Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysis","volume":"61","author":"Xiao","year":"2015","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.12.041_bib72","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/MEG.0000000000001946","article-title":"Accuracy of fibrosis-4 index and non-alcoholic fatty liver disease fibrosis scores in metabolic (dysfunction) associated fatty liver disease according to body mass index: failure in the prediction of advanced fibrosis in lean and morbidly obese individuals","volume":"34","author":"Eren","year":"2022","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.12.041_bib73","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/ajg.2016.453","article-title":"Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis","volume":"112","author":"McPherson","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2025.12.041_bib74","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/hep.22576","article-title":"Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease","volume":"49","author":"Naveau","year":"2009","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.12.041_bib75","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-5926-3-8","article-title":"Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C","volume":"3","author":"Poynard","year":"2004","journal-title":"Comp Hepatol"},{"key":"10.1053\/j.gastro.2025.12.041_bib76","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/jhep.2003.50319","article-title":"Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin","volume":"38","author":"Poynard","year":"2003","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.12.041_bib77","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1111\/jgh.15482","article-title":"Systematic review: accuracy of the enhanced liver fibrosis test for diagnosing advanced liver fibrosis and cirrhosis","volume":"36","author":"Sharma","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.12.041_bib78","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1053\/j.gastro.2018.01.005","article-title":"Accuracy of the enhanced liver fibrosis test vs FibroTest, elastography, and indirect markers in detection of advanced fibrosis in patients with alcoholic liver disease","volume":"154","author":"Thiele","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.12.041_bib79","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.jhep.2022.07.020","article-title":"Head-to-head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD","volume":"77","author":"Kim","year":"2022","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.12.041_bib80","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1053\/he.2000.5852","article-title":"A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts","volume":"31","author":"Malinchoc","year":"2000","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.12.041_bib81","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.12.041_bib82","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1053\/j.gastro.2006.02.010","article-title":"Evidence-based incorporation of serum sodium concentration into MELD","volume":"130","author":"Biggins","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.12.041_bib83","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1093\/clinchem\/46.12.2050","article-title":"Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring","volume":"46","author":"Dufour","year":"2000","journal-title":"Clin Chem"},{"key":"10.1053\/j.gastro.2025.12.041_bib84","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1053\/j.gastro.2021.08.050","article-title":"MELD 3.0: The Model for End-Stage Liver Disease updated for the modern era","volume":"161","author":"Kim","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.12.041_bib85","first-page":"50","article-title":"Surgery and portal hypertension. In: Child CG, ed. The Liver and Portal Hypertension","author":"Child","year":"1964","journal-title":"Philadelphia: Saunders"},{"key":"10.1053\/j.gastro.2025.12.041_bib86","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the esophagus for bleeding oesophageal varices","volume":"60","author":"Pugh","year":"1973","journal-title":"Br J Surg"},{"key":"10.1053\/j.gastro.2025.12.041_bib87","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/hep.31558","article-title":"Risk prediction models for post-operative mortality in patients with cirrhosis","volume":"73","author":"Mahmud","year":"2021","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.12.041_bib88","doi-asserted-by":"crossref","first-page":"e1121","DOI":"10.1016\/j.cgh.2021.06.050","article-title":"Risk prediction models for postoperative decompensation and infection in patients with cirrhosis: a Veterans Affairs cohort study","volume":"20","author":"Mahmud","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.12.041_bib89","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis","volume":"75","author":"Maddrey","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.12.041_bib90","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJM199202203260802","article-title":"A randomized trial of prednisolone in patients with severe alcoholic hepatitis","volume":"326","author":"Ramond","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2025.12.041_bib91","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.12.041_bib92","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/ajg.2016.539","article-title":"A day-4 Lille model predicts response to corticosteroids and mortality in severe alcoholic hepatitis","volume":"112","author":"Garcia-Saenz-de-Sicilia","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2025.12.041_bib93","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00535-017-1400-8","article-title":"Immunoglobulin A and liver diseases","volume":"53","author":"Inamine","year":"2018","journal-title":"J Gastroenterol"},{"key":"10.1053\/j.gastro.2025.12.041_bib94","doi-asserted-by":"crossref","first-page":"e365","DOI":"10.1016\/S2352-3026(21)00056-9","article-title":"Polyclonal hypergammaglobulinaemia: assessment, clinical interpretation, and management","volume":"8","author":"Zhao","year":"2021","journal-title":"Lancet Haematol"},{"key":"10.1053\/j.gastro.2025.12.041_bib95","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.17","article-title":"Autoimmune hepatitis","volume":"4","author":"Mieli-Vergani","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1053\/j.gastro.2025.12.041_bib96","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.gtc.2017.01.001","article-title":"IgG4-related disease and the liver","volume":"46","author":"Chen","year":"2017","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1053\/j.gastro.2025.12.041_bib97","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1053\/j.gastro.2015.03.006","article-title":"Features and outcomes of 899 patients with drug-induced liver injury: the DILIN Prospective Study","volume":"148","author":"Chalasani","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.12.041_bib98","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.amjmed.2022.09.026","article-title":"Liver injury associated with turmeric--a growing problem: ten cases from the Drug-Induced Liver Injury Network [DILIN]","volume":"136","author":"Halegoua-DeMarzio","year":"2023","journal-title":"Am J Med"},{"key":"10.1053\/j.gastro.2025.12.041_bib99","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/hep.28813","article-title":"Liver injury from herbal and dietary supplements","volume":"65","author":"Navarro","year":"2017","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.12.041_bib100","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/a-2319-0694","article-title":"Statins in chronic liver disease: review of the literature and future role","volume":"44","author":"Pham","year":"2024","journal-title":"Semin Liver Dis"},{"key":"10.1053\/j.gastro.2025.12.041_bib101","doi-asserted-by":"crossref","first-page":"789","DOI":"10.5604\/16652681.1171749","article-title":"Drug-induced fatty liver disease: an overview of pathogenesis and management","volume":"14","author":"Satapathy","year":"2015","journal-title":"Ann Hepatol"},{"key":"10.1053\/j.gastro.2025.12.041_bib102","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cld.2019.09.007","article-title":"Drug-induced liver injury from statins","volume":"24","author":"Meurer","year":"2020","journal-title":"Clin Liver Dis"},{"key":"10.1053\/j.gastro.2025.12.041_bib103","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2014.03.045","article-title":"Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset","volume":"147","author":"Fontana","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.12.041_bib104","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00004836-199008000-00012","article-title":"\u201cIsolated\u201d elevation of alkaline phosphatase: significance in hospitalized patients","volume":"12","author":"Lieberman","year":"1990","journal-title":"J Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2025.12.041_bib105","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.amjmed.2015.07.033","article-title":"The incidence and outcomes of ischemic hepatitis: a systematic review with meta-analysis","volume":"128","author":"Tapper","year":"2015","journal-title":"Am J Med"},{"key":"10.1053\/j.gastro.2025.12.041_bib106","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/MOG.0000000000001017","article-title":"Update on ischemic hepatitis","volume":"40","author":"Smith","year":"2024","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1053\/j.gastro.2025.12.041_bib107","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/hep.30824","article-title":"Liver injury and failure in critical illness","volume":"70","author":"Horvatits","year":"2019","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.12.041_bib108","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJM198307213090305","article-title":"The clinical importance of a protein-bound fraction of serum bilirubin in patients with hyperbilirubinemia","volume":"309","author":"Weiss","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2025.12.041_bib109","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cld.2007.11.004","article-title":"Cholestasis induced by total parenteral nutrition","volume":"12","author":"Guglielmi","year":"2008","journal-title":"Clin Liver Dis"},{"key":"10.1053\/j.gastro.2025.12.041_bib110","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.humpath.2011.07.008","article-title":"Total parenteral nutrition therapy and liver injury: a histopathologic study with clinical correlation","volume":"43","author":"Naini","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1053\/j.gastro.2025.12.041_bib111","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.cld.2017.06.003","article-title":"The liver in oncology","volume":"21","author":"Dhanasekaran","year":"2017","journal-title":"Clin Liver Dis"},{"key":"10.1053\/j.gastro.2025.12.041_bib112","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41409-023-01992-8","article-title":"Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT)","volume":"58","author":"Mohty","year":"2023","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.gastro.2025.12.041_bib113","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S1470-2045(09)70064-6","article-title":"Management of chemotherapy-associated hepatotoxicity in colorectal liver metastases","volume":"10","author":"Chun","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.gastro.2025.12.041_bib114","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1053\/j.gastro.2025.12.041_bib115","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/HEP.0000000000000045","article-title":"Checkpoint inhibitor hepatotoxicity: pathogenesis and management","volume":"79","author":"Cunningham","year":"2024","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.12.041_bib116","unstructured":"U.S. Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE), Version 5.0. Published November 27, 2017."},{"key":"10.1053\/j.gastro.2025.12.041_bib117","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/MOG.0000000000001015","article-title":"Diagnosis and management of immune mediated liver injury from checkpoint inhibitors","volume":"40","author":"Likhitsup","year":"2024","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1053\/j.gastro.2025.12.041_bib118","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cld.2012.03.011","article-title":"Liver disease in pregnancy","volume":"16","author":"Mufti","year":"2012","journal-title":"Clin Liver Dis"},{"key":"10.1053\/j.gastro.2025.12.041_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2022.100709","article-title":"Trends in gestational age at delivery for intrahepatic cholestasis of pregnancy and adoption of society guidelines","volume":"4","author":"Lagon","year":"2022","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1053\/j.gastro.2025.12.041_bib120","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/GRF.0000000000000494","article-title":"Acute fatty liver of pregnancy","volume":"63","author":"Nelson","year":"2020","journal-title":"Clin Obstet Gynecol"},{"key":"10.1053\/j.gastro.2025.12.041_bib121","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/gut.51.6.876","article-title":"Prospective study of liver dysfunction in pregnancy in Southwest Wales","volume":"51","author":"Ch'ng","year":"2002","journal-title":"Gut"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508526002398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508526002398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T20:44:58Z","timestamp":1788295498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508526002398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":119,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0016508526002398"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2025.12.041","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Abnormal Liver Biochemical Test Results","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2025.12.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Gastroenterological Association Institute. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}